Varicella-Zoster Virus Vaccine Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Vaccines for preventing shingles in older adults
One of the updated Cochrane Reviews from October 2023 is the third update of a review of the effects of vaccines for Herpes Zoster. It was conducted by a team of researchers in Brazil and we asked one of the authors, Juliana Gomes from the Department of Geriatrics and Gerontology at the Federal University of S ão Paulo, to describe its importance and main findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 27, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts

Recombinant Zoster Vaccine After SCT, Procedural Management of Achalasia, Review of Subclinical Hypothyroidism, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 09, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 9, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Shingrix: Is the Hype Justified?
Dr Paul Offit compares Shingrix with Zostavax ® and lays out the recommendations for the new vaccine. (Source: Medscape Infectious Disease Podcast)
Source: Medscape Infectious Disease Podcast - February 13, 2018 Category: Infectious Diseases Authors: Medscape Source Type: podcasts

TWiV 404: Not found
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Rich ConditFrom the twiVivants, follow up on FluMist and Zoster vaccines, Zika virus update, and isolation of a multicomponent animal virus from mosquitoes. Become a patron of TWiV!Links for this episodeFluMist problem (FDA)DA Henderson obituary (NY Times)DA Henderson, smallpox eradicator (TWiV Special)Efficacy of VZV vaccine (Ther Adv Vaccines)Zika virus burden, Puerto Rico (JAMA)Zika virus in Miami Beach (STAT)Congenital brain anomalies and Zika virus (Radiology)Congenital Zika syndrome with arthrogryposis (BMJ)Multicomponent...
Source: This Week in Virology - MP3 Edition - August 28, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

TWiV 403: It's not easy being vaccine
Hosts: Vincent Racaniello, Alan Dove, and Rich ConditThe TWiV team takes on an experimental plant-based poliovirus vaccine, contradictory findings on the efficacy of Flumist, waning protection conferred by Zostavax, a new adjuvanted subunit zoster vaccine. Become a patron of TWiV!Links for this episodeTribunal orders release of PACE trial data (Valerie Eliot Smith)Our request for PACE trial data (virology blog)GM mosquito release on ballot (NPR)Florida Keys Mosquito Control District on TWiV #111Cold chain and virus free plant based polio vaccine (Plant Biotechnol J)Disappointing flu vaccine ef...
Source: This Week in Virology - MP3 Edition - August 21, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Vaccines for preventing herpes zoster (shingles) in older adults
Among the updated Cochrane Reviews in March 2016 is one from a team of researchers in Brazil looking at the effects of vaccines for Herpes Zoster. Anna Gagliardi from the Department of Geriatrics and Gerontology at the Federal University of São Paulo in Brazil describes their findings in this evidence pod. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - April 28, 2016 Category: Journals (General) Authors: Cochrane Source Type: podcasts

Herpes Zoster Rates Are Increasing, but Why?
The idea that varicella vaccination beginning in 1996 is the cause of an increase in shingles cases is not supported by the evidence. (Source: Medscape Infectious Disease Podcast)
Source: Medscape Infectious Disease Podcast - April 14, 2014 Category: Infectious Diseases Authors: Medscape Source Type: podcasts

Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases
Interview with Jeffrey R. Curtis, MD, MS, author of Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - July 3, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA: 2012-07-04, Vol. 308, No. 1, Author Interview
Interview with Jeffrey R. Curtis, MD, MS, author of Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases: Herpes Zoster and Immune-Mediated Diseases (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - July 3, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA: 2011-01-12, Vol. 305, No. 2, Author in the Room ™ Audio Interview
Interview with Steven J. Jacobsen, MD, PhD, author of Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease. Summary Points: 1. The findings suggest that the zoster vaccine is as effective in a community setting with its mixed population and routine clinical practices as was found in the controlled clinical trials. 2. To date, the uptake of the zoster vaccine has been modest due to a number of reasons, including weaknesses in the adult vaccine infrastructure, knowledge and beliefs of clinicians and patients, periodic supply shortfalls, as well as financial reasons. 3. Because zoster and its...
Source: JAMA Author in the Room - February 22, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts

JAMA: 2011-01-12, Vol. 305, No. 2, Author in the Room™ Audio Interview
Interview with Steven J. Jacobsen, MD, PhD, author of Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease. Summary Points: 1. The findings suggest that the zoster vaccine is as effective in a community setting with its mixed population and routine clinical practices as was found in the controlled clinical trials. 2. To date, the uptake of the zoster vaccine has been modest due to a number of reasons, including weaknesses in the adult vaccine infrastructure, knowledge and beliefs of clinicians and patients, periodic supply shortfalls, as well as financial reasons. 3. Because zoster and its...
Source: JAMA Author in the Room - February 22, 2011 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts